West Pharmaceutical Services (WST)

EBITDA Margin

26.17%

TTM · Period ending:

WST logo

WST EBITDA Margin

Latest reported26.17%
WST TTM EBITDA Margin (19.87% → 26.17%)
High-resolution chart · PNG

WST ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

West Pharmaceutical Services EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
10.6071%
8.2763%
8.3469%
10.0159%
11.2885%
12.9269%
14.1548%
21.0245%
21.2925%
20.8851%
14.3874%
8.0783%
7.4593%
7.5169%
13.6354%
13.1993%
12.7669%
12.141%
11.6173%
10.757%
10.2355%
10.4727%
11.6977%
11.9189%
12.7719%
13.1297%
12.9006%
13.3501%
13.3314%
12.9837%
11.7866%
10.8917%
10.5906%
10.836%
11.6499%
1.7771%
1.6652%
0.3995%
-0.364%
7.5023%
7.0111%
6.4209%
6.6522%
-53.3023%
-34.3492%
-11.0435%
11.6942%
15.3088%
15.1974%
13.7793%
10.5482%
20.0143%
16.4235%
14.3076%
11.8042%
17.386%
17.386%
16.1686%
13.073%
25.0225%
19.8653%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.